DETECTION KITS
DETECTION KITS
Viral antigen detection is a key step in vaccine development, enabling accurate monitoring of antigen expression, immunogenicity, and vaccine formulation.
ELISA-based antigen detection kits are specifically designed to quantify viral proteins such as spike protein, spike RBD, spike trimer, and other structural antigens from pathogens like SARS-CoV-2, RSV, rabies virus, and VZV.
These assays support the evaluation of vaccine candidates by confirming antigen quality, stability, and batch consistency across different viral strains and variants.
Allianz Bio, in collaboration with ACRO Biosystems, provides a specialized range of Viral Antigen Detection ELISA Kits optimized for vaccine research.
Key Features
- Broad Viral Coverage – Kits available for RSV (Post-Fusion F0), Rabies (Glycoprotein G), and Varicella Zoster Virus (Glycoprotein E).
- Supports Vaccine R&D – Designed to expand research and development across multiple viral targets.
- High Sensitivity – Capable of detecting low levels of viral antigens accurately.
- High Specificity – Minimizes cross-reactivity, ensuring precise detection of target viruses.
- Reliable Performance – Offers consistent and reproducible results for preclinical and clinical studies.
